6 completed. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 1 | Completed 1 |
Follow HCV 796: new trials by email Literature Review of HCV 796 trials Research Report on HCV 796
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HCV-796 and Midazolam Drug Interaction Study in Healthy Subjects HCV-796, midazolam - Healthy | Phase 1 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 38 | 2007-06-01 | 2007-12-05 |
| Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between HCV-796 and Desipramine HCV-796, Desipramine - Healthy | Phase 1 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 22 | 2007-06-01 | 2008-04-14 |
| Study to Evaluate the Effects of Age & Gender on PK, Safety & Tolerability of HCV-796 Administered to Healthy Subjects HCV-796 - Healthy | Phase 1 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 48 | 2006-11-01 | 2008-04-14 |
| A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder Subjects Peg-Intron, REBETOL, HCV 796 - Hepatitis C | Phase 2 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 246 | 2006-10-01 | 2013-02-11 |
| Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese Men HCV-796 - Healthy | Phase 1 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 24 | 2006-07-01 | 2009-08-18 |
| Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults HCV-796 - Hepatitis C, Hepatic Insufficiency | Phase 1 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 27 | 2006-05-01 | 2008-04-14 |
Hepatitis C (2) · Hepatic Insufficiency (1)
Wyeth is now a wholly owned subsidiary of Pfizer (6)
United States (5) · Japan (1) · Puerto Rico (1)